Organisation paid for research Program year 2025 Source: CMS Open Payments

Virtua Health

Neither a doctor nor a teaching hospital

Research payments

$771,650

137 payments

Through program year 2025, Virtua Health is reported as receiving $771,650 in research payments, across 137 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$72,456	20
2024	Research	$41,642	20
2023	Research	$143,625	29
2022	Research	$346,031	43
2021	Research	$121,259	21
2020	Research	$13,374	2
2019	Research	$33,263	2

Breakdown

Who paid Research payments · program years 2019–2025

Medtronic, Inc. $636,105 121 payments
AstraZeneca AB $52,548 4 payments
Tosoh Bioscience, Inc. $46,142 1 payment
AstraZeneca Pharmaceuticals LP $27,382 8 payments
AngioDynamics, Inc. $8,773 2 payments
Novartis Pharmaceuticals Corporation $700 1 payment

Studies the money was for Research payments · program years 2019–2025

Leadr $287,850 23 payments
Alleviate-Hf $88,391 29 payments
EV ICD Pivotal $74,449 31 payments
A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma. $52,548 4 payments
Heart Failure Performance Measurement Pilot $47,250 1 payment
CL BNP, St BNP $46,142 1 payment
Linq COPD $41,195 7 payments
AdaptResponse $31,207 9 payments
Psr-Cvg $21,964 13 payments
Spyral Affirm $21,150 3 payments

What the money was spent on Research payments · program years 2019–2025

Other $8,773 2 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.